Caffeine Break – Should We Give Up Coffee for a While?

Caffeine, a naturally occurring methylxanthine alkaloid prevalent in coffee beans, tea leaves, cacao seeds, and select nut varieties, exerts its primary pharmacological effects through competitive antagonism of adenosine receptors within the central nervous system. Adenosine—a purine nucleoside synthesized endogenously—progressively accumulates during wakeful periods, binding to A₁ and A₂A receptors to suppress neuronal excitability, thereby inducing sensations of fatigue and drowsiness. By occupying these receptor sites, caffeine disrupts adenosine’s inhibitory signaling, thereby promoting the enhanced synthesis and release of norepinephrine (which elevates alertness) and dopamine (which improves mood and motivation). Furthermore, the compound modulates prefrontal cortex activity, correlating with improvements in cognitive performance metrics, including sustained attention, information processing speed, and working memory capacity. The pharmacokinetics of caffeine are marked by rapid and near-complete absorption in the small intestine, with peak plasma concentration (Cₘₐₓ) typically attained within 30–60 minutes post-ingestion. Its elimination half-life exhibits substantial interindividual variability, ranging from approximately 3 to 7 hours in adults, influenced by genetic polymorphisms, hepatic metabolism (primarily via cytochrome P450 1A2), and exogenous factors: for instance, tobacco smoking accelerates clearance, whereas pregnancy or concurrent administration of certain drugs (e.g., cimetidine) may prolong it. Contemporary research, including the 2022 study by Reichert and colleagues, underscores dose-dependent variability in physiological responses, necessitating personalized consumption adjustments to mitigate adverse effects such as insomnia, tachycardia, or anxiety disorders.